Page 3 - Randy Acker News Today

CAR-T immunotherapies and antibody drug conjugates will highlight the American Society of Clinical Oncology's cancer research conference that starts Thursday.

These three biotech growth stocks are brimming with potential and could offer massive upside for patient investors.

Clinical-stage biotechnology company Curevo Vaccine has announced the closing of $26m Series A1 financing round.

Have the days of considering gold a 'safe-haven' asset expired and been replaced with ASX 200 healthcare shares? We take a closer look.

ALTOONA, Pennsylvania — On July 24, Democratic Lt. Gov. John Fetterman tweeted a photo of himself with a bemused look on his face next to a Sheetz gas pump with the $106.86 amount he had to pay to fill up his vehicle.

Technology is continuing to transform the events industry with some of the most innovative events, products and ideas. Take a look at the latest happenings! Vault Health Virtual healthcare platform Vault Health rebranded its subsidiary FSSolutions to fall under the Vault Health branding and logo. COVID-19 solutions, including testing and vaccine tracking for the events industry, is one of the company’s main product offerings.  

Andy Acker is a portfolio manager at Janus Henderson Investors responsible for managing the global life sciences and biotechnology strategies since 2007 and 2018, respectively. He also leads the firm’s health care sector research team. Andy received his bachelor of science degree in biochemical sciences from Harvard University, graduating magna cum laude and Phi Beta Kappa. He also earned an MBA with honours from Harvard Business School. Andy holds the Chartered Financial Analyst designation a...

Investegate announcements from RTW Venture Fund Ltd, Additional Investment in Magnolia Medical

/PRNewswire/ -- Magnolia Medical Technologies, Inc., inventors of Steripath®, the only FDA 510(k)-cleared device platform indicated to reduce blood culture...

/PRNewswire/ -- Magnolia Medical Technologies, Inc., inventors of Steripath®, the only FDA 510(k)-cleared device platform indicated to reduce blood culture...